Cancer Diagnostics, Inc.

Cancer Diagnostics, Inc. is a Corporation (For-Profit) registered in BIRMINGHAM, United States and holds an LEI in its own name.

The LEI has been on record for 2 years, since 23 Oct 2024. That is about 6 years later than the median LEI in United States (2019).

The next annual re-validation is due 7 Sep 2027, 314 days from now.

This archive holds 2 versions of the record. The most recent change was on 8 Sep 2026 and altered the legal form, lei status, registration status, jurisdiction, legal address, city, hq address, next renewal; the oldest version we hold dates from 6 Jul 2026. GLEIF publishes only the current state, so superseded values are not available from the source.

The LEI is issued and maintained by Bloomberg Finance L.P., one of the Local Operating Units accredited by GLEIF.

No direct accounting-consolidating parent is reported, because its parent is one or more natural persons, who are outside the LEI system. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because its parent is one or more natural persons, who are outside the LEI system. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is issued, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.